Evidence map›Paper›PMID 41685899›Full record

ArticleMicrobiology spectrum2026

Assessment of the revision of the 2025 CLSI breakpoints for the interpretation of minocycline susceptibility for

Xiaochen Yu, Yanhua Liu, Jinye Du, Fupin Hu, Dandan Yin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaochen Yu *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai, China.
Yanhua Liu *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai, China.
Jinye DuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai, China.ORCID 0000-0002-4493-0619
Dandan YinInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai, China.ORCID 0000-0003-0417-158X

Funding

China Antimicrobial Surveillance Network 2020QD049Shanghai Antimicrobial Surveillance Network 3030231003
6 · The paper itself

Abstract

To evaluate the revision to the 2025 Clinical and Laboratory Standard Institute (CLSI) breakpoints revision on the interpretation of minocycline for IMPORTANCE: The Clinical and Laboratory Standards Institute (CLSI) has made a comprehensive revision of minocycline breakpoints for

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsMinocyclineAcinetobacter InfectionsCarbapenemsChinaHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsMinocyclineAcinetobacter baumanniibreakpointminocyclinesusceptibility testing

Identifiers

PMID41685899
PMCPMC13055231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.